Phone app and edible tags aim to boost HIV pill adherence
NCT ID NCT06465862
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to test a new system that uses tiny silica particles on HIV medication (Biktarvy) and a smartphone app to help people track whether they have taken their pills. The goal was to see if the system is easy to use and accurate over 90 days. However, the study was withdrawn before any participants were enrolled, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Biktarvy (antiretroviral pill) tagged with silica microparticles
- What this could lead to
- If successful, this system could provide a simple way for people with HIV to track their daily medication using a smartphone, potentially improving adherence and health outcomes.
- What could go wrong
- The study was withdrawn before enrolling any participants, so no data were collected. The technology depends on specific phone models and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPLIANCE, MEDICATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Peer support may lift the cloud of loneliness for older gay men with HIV
- Can peer mentors help gay men with HIV stay in care?
- HIV and hidden health risks: a major study probes the link
- Faith-Based therapy aims to heal trauma in young women
- Bringing HIV care to the community: a new test in zambia
- Could intense workouts reverse cognitive decline in older HIV patients?